Excellent proliferation and persistence of allogeneic donor-derived 41-BB based CAR-T cells despite immunosuppression with cyclosporine A

被引:13
作者
Ayuk, Francis [1 ]
Fehse, Boris
Janson, Dietlinde
Berger, Carolina
Riecken, Kristoffer
Kroeger, Nicolaus
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany
关键词
LEUKEMIA; TRANSPLANTATION; CHILDREN;
D O I
10.3324/haematol.2019.245969
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:E322 / E324
页数:3
相关论文
共 15 条
  • [1] Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma
    Ayuk, F
    Shimoni, A
    Nagler, A
    Schwerdtfeger, R
    Kiehl, M
    Sayer, HG
    Zabelina, T
    Zander, AR
    Kröger, N
    [J]. LEUKEMIA, 2004, 18 (03) : 659 - 662
  • [2] Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease
    Brudno, Jennifer N.
    Somerville, Robert P. T.
    Shi, Victoria
    Rose, Jeremy J.
    Halverson, David C.
    Fowler, Daniel H.
    Gea-Banacloche, Juan C.
    Pavletic, Steven Z.
    Hickstein, Dennis D.
    Lu, Tangying L.
    Feldman, Steven A.
    Iwamoto, Alexander T.
    Kurlander, Roger
    Maric, Irina
    Goy, Andre
    Hansen, Brenna G.
    Wilder, Jennifer S.
    Blacklock-Schuver, Bazetta
    Hakim, Frances T.
    Rosenberg, Steven A.
    Gress, Ronald E.
    Kochenderfer, James N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) : 1112 - +
  • [3] Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
    Collins, RH
    Shpilberg, O
    Drobyski, WR
    Porter, DL
    Giralt, S
    Champlin, R
    Goodman, SA
    Wolff, SN
    Hu, W
    Verfaillie, C
    List, A
    Dalton, W
    Ognoskie, N
    Chetrit, A
    Antin, JH
    Nemunaitis, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 433 - 444
  • [4] Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia
    Dai, Hanren
    Zhang, Wenying
    Li, Xiaolei
    Han, Qingwang
    Guo, Yelei
    Zhang, Yajing
    Wang, Yao
    Wang, Chunmeng
    Shi, Fengxia
    Zhang, Yan
    Chen, Meixia
    Feng, Kaichao
    Wang, Quanshun
    Zhu, Hongli
    Fu, Xiaobing
    Li, Suxia
    Han, Weidong
    [J]. ONCOIMMUNOLOGY, 2015, 4 (11):
  • [5] Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
    Gardner, Rebecca A.
    Finney, Olivia
    Annesley, Colleen
    Brakke, Hannah
    Summers, Corinne
    Leger, Kasey
    Bleakley, Marie
    Brown, Christopher
    Mgebroff, Stephanie
    Kelly-Spratt, Karen S.
    Hoglund, Virginia
    Lindgren, Catherine
    Oron, Assaf P.
    Li, Daniel
    Riddell, Stanley R.
    Park, Julie R.
    Jensen, Michael C.
    [J]. BLOOD, 2017, 129 (25) : 3322 - 3331
  • [6] Donor CD19 CART cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity
    Ghosh, Arnab
    Smith, Melody
    James, Scott E.
    Davila, Marco L.
    Velardi, Enrico
    Argyropoulos, Kimon V.
    Gunset, Gertrude
    Perna, Fabiana
    Kreines, Fabiana M.
    Levy, Emily R.
    Lieberman, Sophie
    Jay, Hillary V.
    Tuckett, Andrea Z.
    Zakrzewski, Johannes L.
    Tan, Lisa
    Young, Lauren F.
    Takvorian, Kate
    Dudakov, Jarrod A.
    Jenq, Robert R.
    Hanash, Alan M.
    Motta, Ana Carolina F.
    Murphy, George F.
    Liu, Chen
    Schietinger, Andrea
    Sadelain, Michel
    van den Brink, Marcel R. M.
    [J]. NATURE MEDICINE, 2017, 23 (02) : 242 - 249
  • [7] Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
    Kebriaei, Partow
    Singh, Harjeet
    Huls, M. Helen
    Figliola, Matthew J.
    Bassett, Roland
    Olivares, Simon
    Jena, Bipulendu
    Dawson, Margaret J.
    Kumaresan, Pappanaicken R.
    Su, Shihuang
    Maiti, Sourindra
    Dai, Jianliang
    Moriarity, Branden
    Forget, Marie-Andree
    Senyukov, Vladimir
    Orozco, Aaron
    Liu, Tingting
    McCarty, Jessica
    Jackson, Rinelca N.
    Moyes, Judy S.
    Rondon, Gabriela
    Qazilbash, Muzaffar
    Ciurea, Stefan
    Alousi, Amin
    Nieto, Yago
    Rezvani, Katy
    Marin, David
    Popat, Uday
    Hosing, Chitra
    Shpall, Elizabeth J.
    Kantarjian, Hagop
    Keating, Michael
    Wierda, William
    Do, Kim Anh
    Largaespada, David A.
    Lee, Dean A.
    Hackett, Perry B.
    Champlin, Richard E.
    Cooper, Laurence J. N.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (09) : 3363 - 3376
  • [8] GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS
    KOLB, HJ
    SCHATTENBERG, A
    GOLDMAN, JM
    HERTENSTEIN, B
    JACOBSEN, N
    ARCESE, W
    LJUNGMAN, P
    FERRANT, A
    VERDONCK, L
    NIEDERWIESER, D
    VANRHEE, F
    MITTERMUELLER, J
    DEWITTE, T
    HOLLER, E
    ANSARI, H
    [J]. BLOOD, 1995, 86 (05) : 2041 - 2050
  • [9] The effects of Cyclosporine A and azathioprine on human T cells activated by different costimulatory signals
    Leitner, Judith
    Drobits, Karin
    Pickl, Winfried F.
    Majdic, Otto
    Zlabinger, Gerhard
    Steinberger, Peter
    [J]. IMMUNOLOGY LETTERS, 2011, 140 (1-2) : 74 - 80
  • [10] ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE
    MACKINNON, S
    PAPADOPOULOS, EB
    CARABASI, MH
    REICH, L
    COLLINS, NH
    BOULAD, F
    CASTROMALASPINA, H
    CHILDS, BH
    GILLIO, AP
    KERNAN, NA
    SMALL, TN
    YOUNG, JW
    OREILLY, RJ
    [J]. BLOOD, 1995, 86 (04) : 1261 - 1268